Related Experiment Video
Updated: Aug 16, 2025

Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance
Published on: September 27, 2024
Hydrogen Peroxide-Activated Nitric Oxide-Releasing Vancomycin-Loaded Electrostatic Complexation for Efficient
Xiangjun Chen1, Wenting Li1, Xinyu Jiang1
1School of Pharmacy, Shandong New Drug Loading and Release Technology and Preparation Engineering Laboratory, Binzhou Medical University, 346 Guanhai Road, Yantai264003, P. R. China.
Abstract:
The treatment of subcutaneous abscesses has been greatly hindered due to the spread of drug-resistant strains such as methicillin-resistant Staphylococcus aureus (MRSA). Thus, alternative strategies are highly desired to complement conventional antibiotic therapies and surgical intervention. As one of such strategies, applications of nitric oxide (NO) have shown great potential in the treatment of bacteria-induced subcutaneous abscesses by improving the efficacy of many therapeutic methods. However, it is extremely challenging to achieve precise delivery and controlled release because of its gaseous nature. In the present study, an effective strategy was reported in which on demand hydrogen peroxide (H2O2)-activated nitric oxide-releasing vancomycin (Van)-loaded electrostatic complexation (Lipo/Van@Arg) was fabricated. In this system, Van was encapsulated into a negative-charged DSPG/Chol liposome (Lipo/Van) and electrostatically bound with the positive-charged l-arginine (l-Arg). As expected, Lipo/Van@Arg exhibited superior bacterial binding and biofilm penetration abilities. After being in the interior of the biofilms, Lipo/Van@Arg could be triggered by the endogenous H2O2 and effectively release NO. The released NO could exhibit combined antibacterial and biofilm eradication effects with Van. Moreover, an in vivo evaluation using a BALB/c mouse model of subcutaneous abscesses indicated that the combination treatment of NO and Van based on Lipo/Van@Arg could effectively eliminate MRSA from the abscesses, thereby preventing abscess recurrence. In summary, the Lipo/Van@Arg system developed in this study realized controlled delivery and precise release of NO, which had significant clinical implications in the efficient treatment of abscesses.
Insights
A novel drug delivery system releases nitric oxide (NO) and vancomycin (Van) on demand to combat drug-resistant bacteria like MRSA in subcutaneous abscesses, improving treatment efficacy.
Area of Science:
- Biomedical Engineering
- Drug Delivery Systems
- Antimicrobial Research
Background:
- Subcutaneous abscess treatment is challenged by drug-resistant bacteria, notably methicillin-resistant Staphylococcus aureus (MRSA).
- Nitric oxide (NO) shows promise for enhancing antimicrobial therapies, but its gaseous nature complicates precise delivery and controlled release.
- Existing treatments often require complementary strategies to overcome antibiotic resistance and improve efficacy.
Purpose of the Study:
- To develop an on-demand, hydrogen peroxide (H2O2)-activated nitric oxide (NO)-releasing system for treating subcutaneous abscesses.
- To fabricate and characterize a vancomycin (Van)-loaded electrostatic complexation system (Lipo/Van@Arg) for enhanced drug delivery.
- To evaluate the in vitro and in vivo efficacy of the developed system against MRSA-induced subcutaneous abscesses.
Main Methods:
- Fabrication of vancomycin-loaded liposomes (Lipo/Van) and their electrostatic complexation with l-arginine (Lipo/Van@Arg).
- In vitro assessment of bacterial binding, biofilm penetration, and NO release triggered by H2O2.
- In vivo evaluation of Lipo/Van@Arg efficacy in a BALB/c mouse model of MRSA-induced subcutaneous abscesses.
Main Results:
- Lipo/Van@Arg demonstrated enhanced bacterial binding and biofilm penetration capabilities.
- The system effectively released NO upon encountering endogenous H2O2 within biofilms.
- Combined NO and Van treatment via Lipo/Van@Arg successfully eliminated MRSA and prevented abscess recurrence in vivo.
Conclusions:
- The developed Lipo/Van@Arg system enables controlled NO delivery and precise release, offering a promising strategy for abscess treatment.
- This approach synergistically combines the effects of NO and Vancomycin for potent antibacterial and biofilm eradication.
- The study highlights significant clinical implications for improving the efficiency of subcutaneous abscess treatment, particularly against resistant strains.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Methods of Sterilization II: Chemical Methods
Using chemical sterilization rather than heat to clean out equipment is recommended. It eradicates and removes all bacteria,...
Hand hygiene
Hand washing...
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...

